OKYO Pharma Announces Acceptance of Urcosimod Phase 2 Study Results for Presentation at Prestigious ASCRS Annual Meeting
OKYO Pharma Announces Acceptance of Urcosimod Phase 2 Study Results for Presentation at Prestigious ASCRS Annual Meeting
OKYO Pharma Announces New Data Showing Favorable Corneal Nerve Outcomes in Phase 2 Study for Neuropathic Corneal Pain
OKYO Pharma Announces Registration Pathway with 100 Patient Multi-Center Clinical Trial of Urcosimod in Neuropathic Corneal Pain
FinEx Metals Granted Exploration License For Kero Project in Finland, Adding District-Scale Gold Upside Near Kittila and Ikkari Deposits
Osisko Metals Launches Deep Porphyry Exploration Project and Confirms 852 Metres Averaging 0.95% CuEq at Historic Porphyry Mountain Deposit
